Search Results
Oct 22, 2025, 16:15 ET Peoples Company Acquires Murray Wise Associates from Farmland Partners Inc.
acquired 100% of the equity interests in MWA in November 2021, adding approximately 16,700 acres to its management portfolio at the time and creating a joint asset management platform. "MWA has a talented team that has partnered closely with farmers and clients
More news about: Peoples Company
Oct 21, 2025, 09:51 ET Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia
local physicians to refine their MWA skills under the guidance of esteemed international experts, marking a significant step in the global expansion of this minimally invasive therapy. Baird Medical continues to play an integral role in empowering physicians to deliver MWA treatments safely and effectively.
More news about: BDMD
Oct 20, 2025, 08:30 ET Baird Medical Champions Global Collaboration in Microwave Ablation at International Thyroid Workshop
worldwide, we advance MWA innovation and accelerate best practices to improve patient care. Our mission is to empower physicians shaping the future of minimally invasive treatment." The workshop underscores a growing international consensus on the benefits of MWA as a safe and effective,
More news about: BDMD
Oct 16, 2025, 08:30 ET Baird Medical's MWA Technology Successfully Treats Large Thyroid Nodules at UCSF Health
Medical. "These successful procedures demonstrate the real-world impact of our MWA technology, confirming its value as a safe, effective, and patient-centric alternative to surgery." The procedures highlight MWA as a compelling, non-surgical alternative for patients with large thyroid
More news about: BDMD
Oct 14, 2025, 08:30 ET Baird Medical Highlights Johns Hopkins University Research Demonstrating Clinical and Economic Benefits of Thyroid Nodule Ablation
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("BAIRD MEDICAL" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, highlighted the significant findings of a cost-utility analysis conducted by researchers at Johns Hopkins University. The study abstract,
More news about: BDMD
Oct 09, 2025, 08:30 ET Baird Medical Concludes Successful Participation at ACS Clinical Congress 2025 with Strong Interest in MWA Technology
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, has successfully concluded its participation in the American College of Surgeons (ACS) Clinical Congress 2025, held from October 5-7. The
More news about: BDMD
Oct 06, 2025, 08:30 ET Baird Medical Showcases Advanced Microwave Ablation Technology at the 2025 ACS Clinical Congress
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is participating in the American College of Surgeons (ACS) Clinical Congress 2025 in Chicago, IL. The prestigious event is being held from
More news about: BDMD
Oct 01, 2025, 08:39 ET Baird Medical Advances Microwave Ablation Training at Leading U.S. Thyroid Centers
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, highlighted its recent series of sponsored physician training programs hosted at premier U.S. academic medical centers. Over the past several
More news about: BDMD
Sep 29, 2025, 08:30 ET Baird Medical Showcases Advanced Ablation Technology at 2025 American Thyroid Association Annual Meeting
Medical Center, the session provided a comprehensive clinical overview of MWA. Dr. Kandil presented compelling data from his experience with over 200 MWA procedures. Crucially, his presentation detailed a cohort of 19 patients for whom MWA proved effective after previous Radiofrequency Ablation (RFA) treatments
More news about: BDMD
Sep 19, 2025, 16:31 ET Tüm Senaryolara Uygun Şebeke Oluşturma Teknolojisi, Rüzgar ve Güneş Enerjisini Ana Güç Kaynağı Olarak Hızlandırıyor
müşterinin yüksek irtifa, aşırı soğuk ve zayıf şebeke ortamında şebeke oluşturma ESS çözümünü uygulamasına yardımcı oldu. Bu çözüm, PV çıkışını 1,5 MW'tan 12 MW'a çıkarıyor. Sektördeki diğer çözümlerle karşılaştırıldığında, Huawei'nin çözümü %75 daha fazla enerji entegre ederek proje gelirini büyük ölçüde artırmaktadır.
More news about: Huawei